Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Chinese Services Group WuXi Buys NextCODE Health for $65m

    Jan 9, 2015, 14:00 PM by Michael Croft
    Bio-IT World | WuXi PharmaTech headquartered in Shanghai has acquired NextCODE Health of Iceland for $65 million in cash. The acquisition will merge the WuXi Genome Center with NextCODE to form WuXi NextCODE Genomics.
    Full story
  • Biogen Idec and Columbia University Medical Center to Conduct Collaborative Genetics Research

    Jan 9, 2015, 00:00 AM by Michael Croft
    NEW YORK, NY, UNITED STATES - Jan 9, 2015 - CAMBRIDGE, MA, and NEW YORK, NY (January 9, 2015) - Biogen Idec (NASDAQ: BIIB) and Columbia University Medical Center have formed a $30 million strategic alliance to conduct genetics discovery research on the underlying causes of disease and to identify new treatment approaches
    Full story
  • The What and Why on 2014s Record High Drug Approvals

    Jan 8, 2015, 10:00 AM by Michael Croft
    Forbes | 2014 saw the highest number of new drug applications approved by FDA since 1996, but John LaMattina argues that the year was even more successful than that.
    Full story
  • New Antibiotic Discovered in Dirt

    Jan 8, 2015, 09:00 AM by Michael Croft
    New York Times | Researchers yesterday announced a new antibiotic found in dirt. Teixobactin has not been tested in humans, but was extremely effective in animal tests.
    Full story
  • CLIRINX Launches New CTMS System for Academc Clinical Research

    Jan 8, 2015, 00:00 AM by Michael Croft
    DUBLIN, IRELAND - Jan 8, 2015 - CLIRINX Ltd. announced today that it has launched a new web-based platform for clinical research. The software allows researchers manage their studies and collect medical research data using a sophisticated, web-based system
    Full story
  • Novartis Deal Signals Big Pharma's Entrance in CRISPR-Based Therapies

    Jan 7, 2015, 14:30 PM by Michael Croft
    Bio-IT World | Novartis today became the first big pharma company to announce a CRISPR program, through a deal with Intellia Therapeutics and Caribou Biosciences that will cover CAR-T therapies and hematopoietic stem cell programs.
    Full story
  • 2014's Turning Points in Genomics

    Jan 7, 2015, 11:15 AM by Michael Croft
    Bio-IT World | The $1,000 genome, CRISPR gene therapies, nanopore sequencing, the fall of 23andMe's health service... we look back at six of our most popular stories of 2014, and reflect on how each has developed since.
    Full story
  • Moderna's $450m Investment Brings Funding Total to $950m

    Jan 7, 2015, 09:00 AM by Michael Croft
    Bio-IT World Roundup | Moderna Therapeutics closed a massive private investment round earlier this week, raising $450 million bringing their total funding to $950 million.
    Full story
  • 23andMe Solidifies Business Model with Big Genentech Partnership

    Jan 6, 2015, 13:50 PM by Michael Croft
    Forbes | 23andMe has signed a deal with Genentech to sequence the whole genomes of 3,000 Parkinson's patients and relatives in its customer community, sharing both genetic and clinical data with the big biotech.
    Full story
  • David Mittelman Joins Tute Genomics

    Jan 6, 2015, 10:00 AM by Michael Croft
    Bio-IT World | David Mittelman, co-founder of Arpeggi and GCAT, the Genomics Comparison and Analytic Testing (GCAT) platform, has joined Tute Genomics as CSO.
    Full story
  • American Society for Cell Biology chooses TEMIS for Science Navigator application

    Jan 6, 2015, 00:00 AM by Michael Croft
    COLUMBIA AND BETHESDA, MD - Jan 6, 2015 - Columbia, MD and  Bethesda, MD - January 6, 2015 -  TEMIS, the leading provider of Semantic Content Enrichment solutions for the Enterprise, today announced an extension of their collaboration with the American Society for Cell Biology (ASCB) to further hone the ASCB Science Navigator, a bespoke version of TEMIS Luxid® Navigator - Biopharma Edition, as a tool for biomedical research
    Full story
  • Promising Gene Therapy Company Spark Therapeutics to Go Public

    Jan 5, 2015, 10:55 AM by Michael Croft
    FierceBiotech | Spark Therapeutics, a company with a strong Phase III drug candidate bidding to be the first gene therapy approved for use in the U.S., has filed for an IPO, planning to sell $86 million in public shares.
    Full story
  • With FDA Recommendation, Novartis Heads for First Approval of a Biosimilar

    Jan 5, 2015, 10:30 AM by Michael Croft
    Reuters | In advance of a final decision to be handed down January 7, the FDA today revealed that staff reviewers have recommended approval of a biologic made by Novartis that imitates Amgen's off-patent Neupogen.
    Full story
  • Quanterix Aims for Early Clinical Adoption with High-Throughput Protein Assays

    Jan 2, 2015, 11:20 AM by Michael Croft
    Bio-IT World | Looking to open its highly sensitive Simoa instruments to new customers, Quanterix is opening an accelerator in its Massachusetts lab, where users can test out homebrewed assays in search of new biomarker tests that detect proteins at extremely low concentrations.
    Full story
  • Banner Year for New Drug Approvals

    Jan 2, 2015, 10:00 AM by Michael Croft
    Reuters | 2014 was a banner year for drug approvals, Reuters reports. 41 novel medications were approved, the most since the all-time high of 53 approvals in 1996.
    Full story
  • GE Healthcare - Strategic SWOT Analysis Review

    Jan 2, 2015, 00:00 AM by Michael Croft
    SAN FRANCISCO, CA - Jan 2, 2015 - GE Healthcare - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations
    Full story
  • High-Performance Computing Can Accelerate Life Sciences Discoveries

    Dec 31, 2014, 10:20 AM by Michael Croft
    Bio-IT World | Inside the Box | As petascale supercomputing systems grow more accessible, there is now an opportunity for life sciences researchers to run computations on genomic or molecular data that would be impossible with desktops or small clusters — but only if they are willing to adapt their informatics tools to new computing architectures.
    Full story
  • November and December News and Product Briefs

    Dec 30, 2014, 12:10 PM by Michael Croft
    Bio-IT World | News and product releases from around the industry, including a study of attitudes toward newborn genomic testing, and Definiens' latest tissue quantification software.
    Full story
  • Global Imaging Biomarkers Market Share, Size, Trends, Analysis and Forecasts To 2018

    Dec 30, 2014, 00:00 AM by Michael Croft
    SAN FRANCISCO, CA, UNITED STATES - Dec 30, 2014 - TechNavio's analysts forecast the Global Imaging Biomarkers market to grow at a CAGR of 15.09 percent over the period 2013-2018
    Full story
  • Retraction Watch's Top Retractions of 2014

    Dec 29, 2014, 11:15 AM by Michael Croft
    The Scientist | Adam Marcus and Ivan Oransky, the founders of the Retraction Watch blog, offer their annual list of the year's most prominent, spectacular, or telling retractions in the scientific literature.
    Full story
  • «
  • 371
  • 372
  • 373
  • 374
  • 375
  • 376
  • 377
  • 378 (current)
  • 379
  • 380
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy